Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO)
INR 22.7
(-0.92%)
INR 22.7
(-0.92%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | 1 Billion INR | -6.47% |
| 2021 | 1.07 Billion INR | 53.52% |
| 2020 | 699.44 Million INR | -34.24% |
| 2019 | 1.06 Billion INR | 12.81% |
| 2018 | 942.82 Million INR | 492.68% |
| 2017 | 159.07 Million INR | -7.22% |
| 2016 | 171.46 Million INR | -48.49% |
| 2015 | 332.87 Million INR | -14.54% |
| 2014 | 389.49 Million INR | -24.08% |
| 2013 | 513.02 Million INR | -9.09% |
| 2012 | 564.35 Million INR | 8.15% |
| 2011 | 521.84 Million INR | 257.43% |
| 2010 | 146 Million INR | 91.59% |
| 2009 | 76.2 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q2 | 1.09 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 1 Billion INR | -6.47% |
| 2022 Q4 | 1 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 1.13 Billion INR | 0.0% |
| 2021 Q4 | 1.07 Billion INR | -23.98% |
| 2021 Q2 | 1.14 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | 1.41 Billion INR | 23.86% |
| 2021 FY | 1.07 Billion INR | 53.52% |
| 2020 Q2 | 902.23 Million INR | 0.0% |
| 2020 Q4 | 699.44 Million INR | -6.83% |
| 2020 FY | 699.44 Million INR | -34.24% |
| 2020 Q3 | 750.75 Million INR | -16.79% |
| 2019 Q2 | 928.11 Million INR | 0.0% |
| 2019 Q4 | 1.06 Billion INR | 0.0% |
| 2019 FY | 1.06 Billion INR | 12.81% |
| 2018 Q2 | 262.67 Million INR | 0.0% |
| 2018 Q4 | 942.82 Million INR | 0.0% |
| 2018 FY | 942.82 Million INR | 492.68% |
| 2017 FY | 159.07 Million INR | -7.22% |
| 2017 Q4 | 159.07 Million INR | 0.0% |
| 2017 Q2 | 162.07 Million INR | 0.0% |
| 2016 Q2 | 570.01 Million INR | 0.0% |
| 2016 Q4 | 171.46 Million INR | 0.0% |
| 2016 FY | 171.46 Million INR | -48.49% |
| 2015 Q2 | 484.62 Million INR | 0.0% |
| 2015 Q4 | 332.87 Million INR | 0.0% |
| 2015 FY | 332.87 Million INR | -14.54% |
| 2014 Q4 | 389.49 Million INR | 0.0% |
| 2014 FY | 389.49 Million INR | -24.08% |
| 2013 Q4 | 513.02 Million INR | 0.0% |
| 2013 FY | 513.02 Million INR | -9.09% |
| 2012 FY | 564.35 Million INR | 8.15% |
| 2012 Q4 | 564.35 Million INR | 0.0% |
| 2011 FY | 521.84 Million INR | 257.43% |
| 2011 Q4 | 521.84 Million INR | 0.0% |
| 2010 FY | 146 Million INR | 91.59% |
| 2009 FY | 76.2 Million INR | 0.0% |
| 2009 Q4 | 76.2 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.7 Million INR | -3807.737% |
| Sastasundar Ventures Limited | 1.5 Billion INR | 33.071% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | -0.8% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -4684.802% |
| Vasundhara Rasayans Limited | 53.64 Million INR | -1772.108% |
| Sunil Healthcare Limited | 902.83 Million INR | -11.242% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -47095.959% |
| MedPlus Health Services Limited | 14.27 Billion INR | 92.964% |
| Zenith Healthcare Limited | 24.03 Million INR | -4078.615% |
| Patidar Buildcon Limited | 25.57 Million INR | -3827.46% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | -547.683% |
| Roopa Industries Limited | 493.08 Million INR | -103.682% |
| Smruthi Organics Limited | 485.72 Million INR | -106.771% |
| Trident Lifeline Limited | 331.26 Million INR | -203.183% |
| Bacil Pharma Limited | 1.12 Million INR | -88857.484% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | -381.829% |
| Gujarat Terce Laboratories Limited | 161.67 Million INR | -521.207% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | -749.522% |
| PANJON LTD. | 25.38 Million INR | -3856.703% |
| Tyche Industries Limited | 101.64 Million INR | -888.115% |
| Trimurthi Limited | 101.36 Thousand INR | -990754.38% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -6604.92% |
| Anuh Pharma Limited | 1.54 Billion INR | 34.979% |
| Crestchem Limited | 23.94 Million INR | -4093.97% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -7392.204% |
| Zenlabs Ethica Limited | 301.35 Million INR | -233.272% |
| Vikram Thermo (India) Limited | 291.47 Million INR | -244.567% |
| ANG Lifesciences India Limited | 1.66 Billion INR | 39.556% |
| Parmax Pharma Limited | 117.56 Million INR | -754.257% |
| Fredun Pharmaceuticals Limited | 1.86 Billion INR | 46.041% |
| Deccan Health Care Limited | 111.33 Million INR | -802.071% |
| Shukra Pharmaceuticals Limited | 201.97 Million INR | -397.257% |
| Norris Medicines Limited | 278.17 Million INR | -261.045% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 41.411% |
| Veerhealth Care Limited | 62.78 Million INR | -1499.761% |
| Makers Laboratories Limited | 569.18 Million INR | -76.452% |
| Lactose (India) Limited | 536.39 Million INR | -87.236% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | -20.547% |
| Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | 11.192% |
| Mercury Laboratories Limited | 171.18 Million INR | -486.679% |
| Gennex Laboratories Limited | 535.21 Million INR | -87.651% |
| PRAVEG LIMITED | 767.53 Million INR | -30.851% |
| Denis Chem Lab Limited | 289.82 Million INR | -246.533% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | 41.482% |
| Jenburkt Pharmaceuticals Limited | 201.59 Million INR | -398.199% |
| Colinz Laboratories Limited | 24.1 Million INR | -4066.48% |
| Godavari Drugs Limited | 957.86 Million INR | -4.851% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -335796.321% |
| Zenotech Laboratories Limited | 156.64 Million INR | -541.138% |
| Panchsheel Organics Limited | 340.2 Million INR | -195.216% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | -105.65% |
| Vivanza Biosciences Limited | 148.63 Million INR | -575.72% |
| Phaarmasia Limited | 211.49 Million INR | -374.872% |
| Bharat Parenterals Limited | 2.65 Billion INR | 62.193% |
| Medi-Caps Limited | 63.01 Million INR | -1493.77% |
| DECIPHER LABS LIMITED | 117.72 Million INR | -753.115% |
| Gujarat Themis Biosyn Limited | 197.37 Million INR | -408.849% |
| BDH Industries Limited | 312.53 Million INR | -221.35% |
| Vista Pharmaceuticals Limited | 175.16 Million INR | -473.356% |
| Coral Laboratories Limited | 281.83 Million INR | -256.349% |
| Concord Drugs Limited | 249.88 Million INR | -301.915% |
| Beryl Drugs Limited | 85.63 Million INR | -1072.789% |
| Evoq Remedies Limited | 116.23 Million INR | -764.074% |
| Add-Shop E-Retail Limited | 159.2 Million INR | -530.845% |
| Transchem Limited | 6.72 Million INR | -14845.387% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -11220.221% |
| Parnax Lab Limited | 1.17 Billion INR | 14.212% |
| Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -2292.857% |
| Kerala Ayurveda Limited | 1.05 Billion INR | 5.041% |
| Cian Healthcare Limited | 1.03 Billion INR | 2.902% |
| Trinity League India Limited | 876 Thousand INR | -114549.543% |
| Syschem (India) Limited | 1.07 Billion INR | 6.2% |
| KOBO BIOTECH LIMITED | 2.04 Billion INR | 50.841% |
| Natural Capsules Limited | 1.47 Billion INR | 32.012% |
| Auro Laboratories Limited | 433.09 Million INR | -131.895% |